Repurposing of epalrestat for neuroprotection in parkinson’s disease via activation of the KEAP1/Nrf2 pathway

被引：0
|
作者：
Huafang Jia [1 ]
Mengru Liu [1 ]
Hong Jiang [1 ]
Zhen Qiao [2 ]
Kaiyue Ren [2 ]
Xixun Du [1 ]
Xi Chen [1 ]
Qian Jiao [1 ]
Fengyuan Che [1 ]
机构：
[1] Qingdao Medical College,Department of Physiology, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders and State Key Disciplines, Physiology, School of Basic Medicine
[2] Qingdao University,Shandong Key Laboratory of Neurorehabilitation, School of Life Sciences and Health
[3] University of Health and Rehabilitation Sciences,Shandong Provincial Clinical Research Center for Geriatric Diseases; Key Laboratory of Neurophysiology, Health Commission of Shandong Province; Linyi Key Laboratory of Neurophysiology, Department of Neurolog
[4] Linyi People’s Hospital,undefined
来源：
Journal of Neuroinflammation | / 22卷 / 1期
关键词：
Epalrestat; Parkinson’s disease; KEAP1; Nrf2; Oxidative stress; Mitochondrial dysfunction;
D O I：
10.1186/s12974-025-03455-x
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Keap1 Mutations and Nrf2 Pathway Activation in Epithelial Ovarian Cancer
    Konstantinopoulos, Panagiotis A.
    Spentzos, Dimitrios
    Fountzilas, Elena
    Francoeur, Nancy
    Sanisetty, Srisowmya
    Grammatikos, Alexandros P.
    Hecht, Jonathan L.
    Cannistra, Stephen A.
    CANCER RESEARCH, 2011, 71 (15) : 5081 - 5089
  • [12] Keap1/Nrf2 Pathway Activation Represses Hepatic Gluconeogenesis and Lipogenesis
    Chartoumpekis, Dionysios V.
    Slocum, Stephen L.
    Skoko, John J.
    Wakabayashi, Nobunao
    Aja, Susan
    Yamamoto, Masayuki
    Kensler, Thomas W.
    DIABETES, 2014, 63 : A457 - A457
  • [13] The Keap1/Nrf2 pathway in health and disease: from the bench to the clinic
    O'Connell, Maria A.
    Hayes, John D.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2015, 43 : 687 - 689
  • [14] Tetramethylpyrazine nitrone exerts neuroprotection via activation of PGC-1α/Nrf2 pathway in Parkinson's disease models
    Guo, Baojian
    Zheng, Chengyou
    Cao, Jie
    Luo, Fangcheng
    Li, Haitao
    Hu, Shengquan
    Lee, Simon Mingyuan
    Yang, Xifei
    Zhang, Gaoxiao
    Zhang, Zaijun
    Sun, Yewei
    Wang, Yuqiang
    JOURNAL OF ADVANCED RESEARCH, 2024, 64 : 195 - 211
  • [15] Luteolin Exerts Neuroprotection via Modulation of the p62/Keap1/Nrf2 Pathway in Intracerebral Hemorrhage
    Tan, Xin
    Yang, Yi
    Xu, Jianguo
    Zhang, Peng
    Deng, Ruming
    Mao, Yiguang
    He, Jia
    Chen, Yibin
    Zhang, Yan
    Ding, Jiasheng
    Li, Haiying
    Shen, Haitao
    Li, Xiang
    Dong, Wanli
    Chen, Gang
    FRONTIERS IN PHARMACOLOGY, 2020, 10
  • [16] A Preclinical Model for Parkinson's Disease Based on Transcriptional Gene Activation via KEAP1/NRF2 to Develop New Antioxidant Therapies
    Segura-Aguilar, Juan
    Mannervik, Bengt
    ANTIOXIDANTS, 2023, 12 (03)
  • [17] The NRF2/Keap1 pathway as a therapeutic target in inflammatory bowel disease
    Geertsema, Sem
    Bourgonje, Arno R.
    Fagundes, Raphael R.
    Gacesa, Ranko
    Weersma, Rinse K.
    van Goor, Harry
    Mann, Giovanni E.
    Dijkstra, Gerard
    Faber, Klaas N.
    TRENDS IN MOLECULAR MEDICINE, 2023, 29 (10) : 830 - 842
  • [18] KEAP1 and done? Targeting the NRF2 pathway with sulforaphane
    Dinkova-Kostova, Albena T.
    Fahey, Jed W.
    Kostov, Rumen V.
    Kensler, Thomas W.
    TRENDS IN FOOD SCIENCE & TECHNOLOGY, 2017, 69 : 257 - 269
  • [19] KEAP1 and done? Targeting the NRF2 pathway with sulforaphane
    Kensler, Thomas
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [20] Coumarins as Modulators of the Keap1/Nrf2/ARE Signaling Pathway
    Hassanein, Emad H. M.
    Sayed, Ahmed M.
    Hussein, Omnia E.
    Mahmoud, Ayman M.
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2020, 2020
12345